Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis: Results from a phase 2a proof-of-concept study

Amy S. Paller; John Browning; Lawrence Charles Parish; Christopher G. Bunick; Zachary Rome; Neal Bhatia

doi:10.1016/j.jaad.2022.02.060

Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis: Results from a phase 2a proof-of-concept study

Amy S. Paller, John Browning, Lawrence Charles Parish, Christopher G. Bunick, Zachary Rome, Neal Bhatia

Division of Ambulatory Care

Resultado de la investigación: Article › revisión exhaustiva

2 Citas (Scopus)

Idioma original	English (US)
Páginas (desde-hasta)	1189-1191
Número de páginas	3
Publicación	Journal of the American Academy of Dermatology
Volumen	87
N.º	5
DOI	https://doi.org/10.1016/j.jaad.2022.02.060
Estado	Published - nov 2022

ASJC Scopus subject areas

Dermatology

Acceder al documento

10.1016/j.jaad.2022.02.060

Otros archivos y enlaces

Citar esto

Paller, A. S., Browning, J., Parish, L. C., Bunick, C. G., Rome, Z., & Bhatia, N. (2022). Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis: Results from a phase 2a proof-of-concept study. Journal of the American Academy of Dermatology, 87(5), 1189-1191. https://doi.org/10.1016/j.jaad.2022.02.060

Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis : Results from a phase 2a proof-of-concept study. / Paller, Amy S.; Browning, John; Parish, Lawrence Charles et al.

En: Journal of the American Academy of Dermatology, Vol. 87, N.º 5, 11.2022, p. 1189-1191.

Resultado de la investigación: Article › revisión exhaustiva

Paller, AS, Browning, J, Parish, LC, Bunick, CG, Rome, Z & Bhatia, N 2022, 'Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis: Results from a phase 2a proof-of-concept study', Journal of the American Academy of Dermatology, vol. 87, n.º 5, pp. 1189-1191. https://doi.org/10.1016/j.jaad.2022.02.060

@article{9cceef276ffb4ebc8fd4171e290543c9,

title = "Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis: Results from a phase 2a proof-of-concept study",

keywords = "congenital ichthyosis, isotretinoin, retinoids, scaling, topical therapy",

author = "Paller, {Amy S.} and John Browning and Parish, {Lawrence Charles} and Bunick, {Christopher G.} and Zachary Rome and Neal Bhatia",

note = "Funding Information: Funding sources: Supported by Patagonia Pharmaceuticals and a grant from the US Food and Drug Administration ( 1R01FD006079-01A1 ). Funding Information: Medical writing and editorial assistance were provided by Zehra Gundogan, VMD, of AlphaBioCom, LLC, under the direction of the authors and funded by Timber Pharmaceuticals.",

year = "2022",

month = nov,

doi = "10.1016/j.jaad.2022.02.060",

language = "English (US)",

volume = "87",

pages = "1189--1191",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis

T2 - Results from a phase 2a proof-of-concept study

AU - Paller, Amy S.

AU - Browning, John

AU - Parish, Lawrence Charles

AU - Bunick, Christopher G.

AU - Rome, Zachary

AU - Bhatia, Neal

N1 - Funding Information: Funding sources: Supported by Patagonia Pharmaceuticals and a grant from the US Food and Drug Administration ( 1R01FD006079-01A1 ). Funding Information: Medical writing and editorial assistance were provided by Zehra Gundogan, VMD, of AlphaBioCom, LLC, under the direction of the authors and funded by Timber Pharmaceuticals.

PY - 2022/11

Y1 - 2022/11

KW - congenital ichthyosis

KW - isotretinoin

KW - retinoids

KW - scaling

KW - topical therapy

UR - http://www.scopus.com/inward/record.url?scp=85127320828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127320828&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2022.02.060

DO - 10.1016/j.jaad.2022.02.060

M3 - Article

C2 - 35271936

AN - SCOPUS:85127320828

SN - 0190-9622

VL - 87

SP - 1189

EP - 1191

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 5

ER -